secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
CIK:        0000315545
Form:       8-K
Filed at:   2026-04-21T23:59:59+00:00
Accession:  0001493152-26-018160
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Provectus to hold 2026 annual meeting at planned new headquarters, Perkins Place in Knoxville
--------------------------------------------------------------------------------

- Annual meeting set for June 18, 2026 at 4:00 p.m. ET at Perkins Place, 525 Portland Street, Knoxville.
- Company plans to relocate headquarters to Perkins Place in 2026; first stockholder gathering at new location.
- Perkins Place is a 22,941 sq ft renovated historic school building on 3.23 acres with expansion potential.
- Chairman & CEO Ed Pershing reacquired property in fall 2025 via partnership with East Tennessee Foundation.
- Relocation cited to manage costs and enable future facility development for research, operations, or logistics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/315545/000149315226018160/0001493152-26-018160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/315545/000149315226018160/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-018160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer